{
    "clinical_study": {
        "@rank": "82511", 
        "brief_summary": {
            "textblock": "To compare the antiviral effect of stavudine ( d4T ) versus placebo in patients with\n      evidence of recent HIV infection.\n\n      Also, to compare the immunologic effects and effects on quality of life of d4T in these\n      patients."
        }, 
        "brief_title": "A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.", 
        "completion_date": {
            "#text": "May 1999", 
            "@type": "Actual"
        }, 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "HIV Infections", 
                "Acquired Immunodeficiency Syndrome"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients receive d4T or placebo every 12 hours for 4 weeks, after which dose decreases (or\n      placebo) every 12 hours. Treatment continues for at least 48 weeks."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Patients must have:\n\n          -  Recent HIV infection.\n\n          -  No prior antiretroviral therapy.\n\n          -  No acute opportunistic infection at study entry.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following symptoms or conditions are excluded:\n\n          -  Intractable diarrhea.\n\n          -  Bilateral peripheral neuropathy.\n\n          -  Any other condition that would preclude study therapy.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Myelosuppressive, neurotoxic, or hepatotoxic drugs.\n\n        Patients with the following prior condition are excluded:\n\n        History of bilateral peripheral neuropathy.\n\n        Prior Medication:\n\n        Excluded:\n\n          -  Prior antiretroviral therapy.\n\n          -  Myelosuppressive, neurotoxic, or cytotoxic agents within 3 months prior to study\n             entry."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "40", 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002349", 
            "org_study_id": "244A", 
            "secondary_id": "AI455-029"
        }, 
        "intervention": {
            "intervention_name": "Stavudine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Antiviral Agents", 
                "Stavudine"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "AIDS-Related Complex", 
            "Stavudine"
        ], 
        "lastchanged_date": "April 13, 2011", 
        "link": [
            {
                "description": "BMS Clinical Trials Disclosure", 
                "url": "http://ctr.bms.com/ctd/start.do"
            }, 
            {
                "description": "For FDA Safety Alerts and Recalls refer to the following link www.fda.gov/MEDWATCH/safety.htm", 
                "url": "http://www.fda.gov/MEDWATCH/safety.htm"
            }
        ], 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "San Diego", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "921345000"
                    }, 
                    "name": "San Diego Naval Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Portsmouth", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "237085100"
                    }, 
                    "name": "Naval Med Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98122"
                    }, 
                    "name": "Northwest Med Ctr"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection.", 
        "overall_official": {
            "affiliation": ".", 
            "last_name": ". ., .", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 1999", 
            "@type": "Actual"
        }, 
        "reference": {
            "citation": "Katlama C, Molina JM, Rozenbaum W, Valantin MA, Modai J, Chauveau E, Ngo Van P, Gres JJ. Stavudine ( D4T ) in HIV infected patients with CD4 less than 350/mm3: results of a double-blind randomized placebo controlled study. Conf Retroviruses Opportunistic Infect. 1996 Jan 28-Feb 1;3rd:89"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002349"
        }, 
        "source": "Bristol-Myers Squibb", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bristol-Myers Squibb", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 1995", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2011"
    }, 
    "geocoordinates": {
        "Naval Med Ctr": "36.835 -76.298", 
        "Northwest Med Ctr": "47.606 -122.332", 
        "San Diego Naval Hosp": "32.715 -117.157"
    }
}